文献速递产科

阴道分娩时未被怀疑的胎盘植入谱系疾病:发病率、特征及母体发病率评估

Unsuspected placenta accreta spectrum at vaginal delivery: assessment of incidence, characteristics, and maternal morbidity.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-02-10

本研究为回顾性队列研究,基于2016年1月至2019年12月美国全国住院患者样本中8694669例足月阴道分娩,探讨阴道分娩时 incidental 诊断的胎盘植入谱系疾病(PAS)的发病率、特征及母体结局。结果显示未怀疑的PAS发生率为1/3797,与子宫异常等因子相关,且与出血、输血、子宫切除等严重母体发病率显著相关。

要点

  • 足月阴道分娩中未怀疑的PAS发生率为1/3797。
  • 子宫异常与未怀疑PAS的关联最强(aOR 6.23,95%CI 4.20-9.26)。
  • 未怀疑PAS组出血、输血、子宫切除等母体发病率显著高于无PAS组。

核心结论

  • 本研究提示,尽管足月阴道分娩中未怀疑的胎盘植入谱系疾病罕见,但与显著母体发病率相关。
  • 观察到的子宫异常与胎盘植入谱系疾病之间的关联需进一步研究。

研究设计与样本

  • 回顾性队列研究,使用医疗成本与利用项目全国住院患者样本。
  • 研究人群为2016年1月至2019年12月的8694669例足月阴道分娩。
  • 排除标准包括既往子宫瘢痕、前置胎盘和早产。
  • 暴露根据胎盘植入谱系疾病诊断确定。
  • 采用多变量二元逻辑回归分析和逆概率处理加权进行统计分析。

主要发现

  • 未怀疑的胎盘植入谱系疾病报告率为每3797例阴道分娩中1例。
  • 多变量分析中,与未怀疑胎盘植入谱系疾病可能性增加相关的因素包括(均P<.05):患者因素如年龄较大、子宫因素如子宫异常和子宫肌瘤、妊娠因素如早期足月分娩和既往复发性妊娠丢失、胎儿因素如宫内生长受限和胎儿死亡。
  • 子宫异常与未怀疑胎盘植入谱系疾病的关联最强(调整比值比6.23;95%置信区间4.20-9.26)。
  • 在倾向评分加权模型中,未怀疑胎盘植入谱系疾病组相比无胎盘植入谱系疾病组更可能发生出血(65.2% vs 4.1%)、血制品输注(21.3% vs 0.6%)、子宫切除(14.9% vs <0.1%)、凝血病(2.9% vs 0.1%)和休克(2.9% vs <0.1%)。
  • 未怀疑胎盘植入谱系疾病组相比无胎盘植入谱系疾病组更可能接受手工剥离胎盘(25.1% vs 0.6%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Placenta accreta spectrum refers to morbidly adherent trophoblastic tissue invading into the gravid uterus and is associated with significant maternal morbidity. Most cases of placenta accreta spectrum are suspected antenatally, and most patients undergo planned, late-preterm cesarean hysterectomy to reduce the risk of morbidity. Rarely, however, placenta accreta spectrum is incidentally diagnosed at vaginal delivery, but there is a scarcity of data regarding these events. OBJECTIVE: This study aimed to examine the incidence, characteristics, and outcomes of pregnant individuals with incidentally diagnosed placenta accreta spectrum at term vaginal delivery. STUDY DESIGN: This was a retrospective cohort study investigating the Healthcare Cost and Utilization Project's National Inpatient Sample. The study population was 8,694,669 term vaginal deliveries from January 2016 to December 2019. Exclusion criteria included previous uterine scar, placenta previa, and preterm delivery. Exposure was assigned by the diagnosis of placenta accreta spectrum. The main outcomes were: (1) incidence rate, (2) clinical and pregnancy characteristics, and (3) maternal morbidity related to unsuspected placenta accreta spectrum at vaginal delivery. Multivariable binary logistic regression analysis and inverse probability of treatment weighting were fitted for statistical analysis. RESULTS: Unsuspected placenta accreta spectrum was reported in 1 in 3797 vaginal deliveries. In a multivariable analysis, the following were associated with increased likelihood of unsuspected placenta accreta spectrum (all, P<.05): (1) patient factor with older age, (2) uterine factors such as uterine anomaly and uterine myoma, (3) pregnancy factors including early-term delivery and previous recurrent pregnancy losses, and (4) fetal factors of in utero growth restriction and demise. Of those, uterine anomaly had the greatest association with unsuspected placenta accreta spectrum (adjusted odds ratio, 6.23; 95% confidence interval, 4.20-9.26). In a propensity score-weighted model, patients in the unsuspected placenta accreta spectrum group were more likely to have hemorrhage (65.2% vs 4.1%), blood product transfusion (21.3% vs 0.6%), hysterectomy (14.9% vs <0.1%), coagulopathy (2.9% vs 0.1%), and shock (2.9% vs <0.1%) compared with those without placenta accreta spectrum. Patients in the unsuspected placenta accreta spectrum group were also more likely to receive manual removal of the placenta compared with those in the non-placenta accreta spectrum group (25.1% vs 0.6%). CONCLUSION: This study suggests that although unsuspected placenta accreta spectrum among patients undergoing term vaginal delivery is rare, it is associated with significant morbidity. The observed association between uterine anomalies and placenta accreta spectrum warrants further investigation.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Rau AR, Youssefzadeh AC, Matsuzaki S, et al. Unsuspected placenta accreta spectrum at vaginal delivery: assessment of incidence, characteristics, and maternal morbidity. Am J Obstet Gynecol MFM. 2023. PMID: 36774226. doi:10.1016/j.ajogmf.2022.100805

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。